91 related articles for article (PubMed ID: 12951044)
1. Induction of plasminogen activator inhibitor-2 is associated with suppression of invasive activity in TPA-mediated differentiation of human prostate cancer cells.
Shimizu T; Sato K; Suzuki T; Tachibana K; Takeda K
Biochem Biophys Res Commun; 2003 Sep; 309(2):267-71. PubMed ID: 12951044
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of genes during TPA-induced differentiation of human prostatic cancer TSU-Pr1 cells.
Suzuki T; Shimizu T; Satoh K; Sugibayashi R; Takeda K
Int J Mol Med; 2002 Dec; 10(6):735-9. PubMed ID: 12430000
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of p21(WAF1/CIP1) leads to morphologic changes and esterase activity in TPA-mediated differentiation of human prostate cancer cell line TSU-Pr1.
Sugibayashi R; Shimizu T; Suzuki T; Yamamoto N; Hamada H; Takeda K
Oncogene; 2001 Mar; 20(10):1220-8. PubMed ID: 11313866
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of p21(WAF1/CIP1) levels leads to growth suppression of prostate cancer cell lines.
Sugibayashi R; Kiguchi Y; Shimizu T; Suzuki T; Hamada H; Takeda K
Anticancer Res; 2002; 22(2A):713-9. PubMed ID: 12014641
[TBL] [Abstract][Full Text] [Related]
5. Effects of N-(4-hydroxyphenyl) retinamide on urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in prostate adenocarcinoma cell lines.
Tanabe T
Hiroshima J Med Sci; 2000 Mar; 49(1):67-72. PubMed ID: 10824459
[TBL] [Abstract][Full Text] [Related]
6. Phorbol ester induces differentiation of a human prostatic cancer cell line TSU-Pr1 into cells with characteristics of microglia.
Itayasu T; Shimizu T; Iizumi T; Oshio S; Umeda T; Takeda K
Anticancer Res; 1998; 18(1A):113-7. PubMed ID: 9568064
[TBL] [Abstract][Full Text] [Related]
7. In vitro anti-invasive effects of N-(4-hydroxyphenyl)-retinamide on human prostatic adenocarcinoma.
Kim JH; Tanabe T; Chodak GW; Rukstalis DB
Anticancer Res; 1995; 15(4):1429-34. PubMed ID: 7654032
[TBL] [Abstract][Full Text] [Related]
8. Low-dose staurosporine suppresses proliferation and induces neurites in human prostatic cancer TSU-Pr1 cells.
Takahashi N; Shimizu T; Takeda K
Prostate; 2000 Sep; 44(4):328-33. PubMed ID: 10951498
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of plasminogen activator inhibitor type 2 in basal keratinocytes enhances papilloma formation in transgenic mice.
Zhou HM; Bolon I; Nichols A; Wohlwend A; Vassalli JD
Cancer Res; 2001 Feb; 61(3):970-6. PubMed ID: 11221892
[TBL] [Abstract][Full Text] [Related]
10. Analysis of gene expression during staurosporine-induced neuronal differentiation of human prostate cancer cells.
Shimizu T; Okayama A; Inoue T; Takeda K
Oncol Rep; 2005 Aug; 14(2):441-8. PubMed ID: 16012728
[TBL] [Abstract][Full Text] [Related]
11. Different regulation of plasminogen activator inhibitor 2 gene expression by phorbol ester and cAMP in human myeloid leukemia cell line PL-21.
Niiya K; Taniguchi T; Shinbo M; Ishikawa T; Tazawa S; Hayakawa Y; Sakuragawa N
Thromb Haemost; 1994 Jul; 72(1):92-7. PubMed ID: 7974383
[TBL] [Abstract][Full Text] [Related]
12. Prevotella intermedia stimulates tissue-type plasminogen activator and plasminogen activator inhibitor-2 expression via multiple signaling pathways in human periodontal ligament cells.
Guan SM; He JJ; Zhang M; Shu L
FEMS Immunol Med Microbiol; 2011 Jun; 62(1):91-100. PubMed ID: 21314733
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of urokinase-type plasminogen activator (uPA), its receptor (uPA-R), and inhibitor type-2 (PAI-2) during differentiation of keratinocytes in an organotypic coculture system.
Schaefer BM; Stark HJ; Fusenig NE; Todd RF; Kramer MD
Exp Cell Res; 1995 Oct; 220(2):415-23. PubMed ID: 7556451
[TBL] [Abstract][Full Text] [Related]
14. Staurosporine enhances the expression of tissue inhibitor of metalloproteinase-1 in human prostate cancer cells.
Tachibana K; Shimizu T; Tonami K; Takeda K
Biochem Biophys Res Commun; 2002 Jul; 295(2):489-94. PubMed ID: 12150976
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of proteolytic activity in 12-O-tetradecanoyl-phorbol-13-acetate-induced K562 leukemia cell cultures: depletion of active urokinase by excess type 1 plasminogen activator inhibitor.
Alitalo R; Andersson LC; Tapiovaara H; Sistonen L; Vaheri A; Stephens R
J Cell Physiol; 1989 Jul; 140(1):119-30. PubMed ID: 2500450
[TBL] [Abstract][Full Text] [Related]
16. Induction of plasminogen activator inhibitor type 2 expression during differentiation of human K562 cells towards a macrophage phenotype.
Rehemtulla A; Arndt A; Hart DA
Biochem Cell Biol; 1990 Dec; 68(12):1337-43. PubMed ID: 1964793
[TBL] [Abstract][Full Text] [Related]
17. A proliferative effect of transforming growth factor-beta1 on a human prostate cancer cell line, TSU-Pr1.
Lamm ML; Sintich SM; Lee C
Endocrinology; 1998 Feb; 139(2):787-90. PubMed ID: 9449654
[TBL] [Abstract][Full Text] [Related]
18. Tumor-promoting phorbol ester-induced cell death and gene expression in a human prostate adenocarcinoma cell line.
Young CY; Murtha PE; Zhang J
Oncol Res; 1994; 6(4-5):203-10. PubMed ID: 7841543
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional and posttranscriptional regulation of type 1 plasminogen activator inhibitor and tissue-type plasminogen activator gene expression in HTC rat hepatoma cells by glucocorticoids and cyclic nucleotides.
Heaton JH; Kathju S; Gelehrter TD
Mol Endocrinol; 1992 Jan; 6(1):53-60. PubMed ID: 1738371
[TBL] [Abstract][Full Text] [Related]
20. Phorbol ester-induced apoptosis is accompanied by NGFI-A and c-fos activation in androgen-sensitive prostate cancer cells.
Day ML; Zhao X; Wu S; Swanson PE; Humphrey PA
Cell Growth Differ; 1994 Jul; 5(7):735-41. PubMed ID: 7947388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
